Literature DB >> 3258438

Oral trimethoprim as follow-up treatment of meningitis caused by Listeria monocytogenes.

G Günther1, A Philipson.   

Abstract

Successful treatment of meningitis and septicemia caused by Listeria monocytogenes with intravenous trimethoprim-sulfamethoxazole has previously been reported. This case report of a 13-year-old boy with meningitis caused by Listeria monocytogenes documents complete cure with 6 days of intravenously administered trimethoprim-sulfamethoxazole followed by orally administered trimethoprim as monotherapy.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3258438     DOI： 10.1093/clinids/10.1.53

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN： 0162-0886


  6 in total

Review 1.  Listeriosis in human pregnancy: a systematic review.

Authors:  Ronald F Lamont; Jack Sobel; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Edi Vaisbuch; Sun Kwon Kim; Niels Uldbjerg; Roberto Romero
Journal:  J Perinat Med       Date:  2011-04-25       Impact factor: 1.901

2.  Cure of Listeria monocytogenes meningitis after early transition to oral therapy.

Authors:  Matthew H Grant; Hannah Ravreby; Bennett Lorber
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

Review 3.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 4.  Management of listeriosis.

Authors:  H Hof; T Nichterlein; M Kretschmar
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 5.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

6.  Two cases of listeria rhombencephalitis.

Authors:  Christopher Thomas Mansbridge; Irina Grecu; Jimmy Sw Li Voon Chong; Clive Vandervelde; Kordo Saeed
Journal:  IDCases       Date:  2017-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.